Vaccination in the immunotherapy of glioblastoma

Human Vaccines & Immunotherapeutics
Ziren KongWenbin Ma

Abstract

Glioblastoma remains one of the most common central nervous system tumors with an extremely poor prognosis. Recently, rapid progress in immunotherapy has provided new options for the treatment of glioblastoma. Vaccination, the primary method of immunotherapy, stimulates the body's tumor-specific immune response by the injection of foreign antigens. Peptide vaccines involve the injection of tumor-specific antigens, such as EGFRvIII or heat-shock proteins. Cell-based vaccines, which primarily include dendritic cell vaccines and tumor cell vaccines, involve injections of ex vivo-modified cells. Despite the encouraging results of phase I/II clinical trials, no successful phase III clinical trials involving glioblastoma immunotherapy, including glioblastoma vaccinations, have been reported to date. In this review, the authors summarize the published outcomes of glioblastoma vaccine therapy, explore its future prospects based on ongoing clinical trials, and discuss combined therapy as a future direction for glioblastoma treatment.

References

Jan 1, 1988·Annual Review of Genetics·S Lindquist, E A Craig
Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K L BlackD P Becker
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 26, 2005·Cell Stress & Chaperones·Daniel R Ciocca, Stuart K Calderwood
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Linda M LiauMichael D Roth
Oct 21, 2005·Journal of Translational Medicine·Amy B HeimbergerKenneth Aldape
Nov 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Arnold I FreemanTali Siegal
Dec 27, 2005·Gene·Nicola NormannoDavid S Salomon
Jul 5, 2006·Neurosurgical Focus·A Sehgal, M S Berger
Aug 4, 2006·Journal of Leukocyte Biology·Jana GoldmannIngo Bechmann
Oct 19, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael W GranerDarell D Bigner
Dec 18, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·David G WalkerChris Schmidt
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Sep 9, 2008·Journal of Immunological Methods·Robert J SchmittlingJohn H Sampson
Nov 26, 2008·Journal of Leukocyte Biology·Bart R TambuyzerEtienne J Nouwen
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Aug 12, 2009·Future Oncology·Christopher G Wood, Peter Mulders
Jan 5, 2010·Immunotherapy·Timothy P Kresowik, Thomas S Griffith
Jul 30, 2010·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Leos KrenJaroslav Michalek
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John H SampsonDarell D Bigner
Oct 30, 2010·Immunity·Robert L CoffmanRobert A Seder
Dec 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert M PrinsLinda M Liau
Jun 23, 2011·Expert Review of Vaccines·Alfred P SeeMichael Lim
Jul 1, 2011·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Chen-Nen ChangWen-Kuang Yang
Mar 23, 2012·Nature Reviews. Cancer·Karolina Palucka, Jacques Banchereau
Apr 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thierry GorliaMartin J van den Bent
Aug 1, 2012·Cancer Immunology, Immunotherapy : CII·Surasak PhuphanichJohn S Yu
Aug 9, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Courtney A CraneAndrew T Parsa
Nov 7, 2012·Current Protocols in Immunology·Smita NairThomas F Tedder

❮ Previous
Next ❯

Citations

Dec 20, 2018·International Journal of Molecular Sciences·Thomas C ChenAxel H Schönthal
Apr 3, 2020·Expert Review of Vaccines·Vaishali Y Londhe, Varada Date
Oct 6, 2020·Neuro-oncology Practice·Megan L MontoyaHideho Okada
Nov 17, 2020·Frontiers in Immunology·Xianhui KangWujun Geng
Mar 7, 2021·Cancers·Hong-My NguyenDipongkor Saha
May 1, 2021·Journal of Personalized Medicine·Vianney GilardSoumeya Bekri
May 28, 2021·Frontiers in Oncology·Stephen C FredericoMasaki Terabe

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
biopsy

Clinical Trials Mentioned

NCT01967758
NCT00905060
NCT02122822
NCT02722512
NCT01814813
NCT03018288
NCT02454634
NCT02960230
NCT02455557
NCT00045968

Software Mentioned

ACTIVATE

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Related Papers

Human Vaccines & Immunotherapeutics
Qiangyi ZhouWenbin Ma
Advances in Experimental Medicine and Biology
Ryuya Yamanaka, Koji Kajiwara
International Journal of Oncology
Ryuya YamanakaRyuichi Tanaka
© 2022 Meta ULC. All rights reserved